XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue (Tables)
 3 Months Ended
Dec. 30, 2023
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:    
Three Months Ended December 30, 2023
Business (in millions)
United StatesInternationalTotal
Diagnostics:
Cytology & Perinatal$69.8 $50.2 $120.0 
Molecular Diagnostics247.6 72.2 319.8 
Blood Screening8.0 — 8.0 
Total$325.4 $122.4 $447.8 
Breast Health:
Breast Imaging$228.4 $73.0 $301.4 
Interventional Breast Solutions61.1 15.2 76.3 
Total$289.5 $88.2 $377.7 
GYN Surgical$125.1 $37.1 $162.2 
Skeletal Health$13.7 $11.7 $25.4 
$753.7 $259.4 $1,013.1 


Three Months Ended December 31, 2022
Business (in millions)
United StatesInternationalTotal
Diagnostics:
Cytology & Perinatal$78.2 $48.6 $126.8 
Molecular Diagnostics328.2 97.0 425.2 
Blood Screening7.3 — 7.3 
Total$413.7 $145.6 $559.3 
Breast Health:
Breast Imaging$212.2 $52.2 $264.4 
Interventional Breast Solutions57.8 12.0 69.8 
Total$270.0 $64.2 $334.2 
GYN Surgical$123.1 $31.0 $154.1 
Skeletal Health$16.8 $9.8 $26.6 
$823.6 $250.6 $1,074.2 
Three Months Ended
Geographic Regions (in millions)
December 30, 2023December 31, 2022
United States$753.7 $823.6 
Europe142.8 147.4 
Asia-Pacific63.8 63.8 
Rest of World52.8 39.4 
$1,013.1 $1,074.2 

The following table provides revenue recognized by source:

Three Months Ended
Revenue by type (in millions)
December 30, 2023December 31, 2022
Disposables$628.9 $727.8 
Capital equipment, components and software199.2 158.5 
Service178.8 183.3 
Other6.2 4.6 
$1,013.1 $1,074.2